Home > Balance Sheet > MARKSANS PHARMA

MARKSANS PHARMA
Contingent Liabilities

    Back to Balance Sheet
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Contingent Liabilities ₹1.45 Cr₹1.45 Cr₹20 Cr₹48 Cr₹30 Cr

What is the latest Contingent Liabilities ratio of MARKSANS PHARMA ?

The latest Contingent Liabilities ratio of MARKSANS PHARMA is ₹1.45 Cr based on Mar2023 Consolidated results.
Year Contingent Liabilities
Mar2023₹1.45 Cr
Mar2022₹1.45 Cr
Mar2021₹20 Cr
Mar2020₹48 Cr
Mar2019₹30 Cr

How is Contingent Liabilities of MARKSANS PHARMA Trending?

Years Contingent Liabilities % Change
Mar2023 ₹1.45 Cr
0.00
Mar2022 ₹1.45 Cr
-92.68
Mar2021 ₹20 Cr
-58.94
Mar2020 ₹48 Cr
58.45
Mar2019 ₹30 Cr -

Compare Contingent Liabilities of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹7,665.9 Cr 5.2% -2.2% 123.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,470.0 Cr -0.9% 0.9% 62.6% Stock Analytics
CIPLA ₹112,990.0 Cr 3.5% 4.2% 51.8% Stock Analytics
ZYDUS LIFESCIENCES ₹105,846.0 Cr 12.2% 18% 103.8% Stock Analytics
DIVIS LABORATORIES ₹103,849.0 Cr 0.8% 5.6% 19.3% Stock Analytics
DR REDDYS LABORATORIES ₹96,742.1 Cr -1% -2.4% 28.4% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

5.2%

-2.2%

123.9%

SENSEX

1.7%

0.7%

19.2%


You may also like the below Video Courses